Live Variola Virus: Considerations for Continuing Research (2009)

Chapter: 7 Development of Vaccines

Previous Chapter: 6 Development of Therapeutics
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 87
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 88
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 89
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 90
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 91
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 92
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 93
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 94
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 95
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 96
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 97
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 98
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 99
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 100
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 101
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 102
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 103
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 104
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 105
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 106
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 107
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 108
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 109
Suggested Citation: "7 Development of Vaccines." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Page 110
Next Chapter: 8 Methods for Detection and Diagnosis
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.